Markets
News
Analysis
Tools
Learn
English
繁体中文
ไทย
Tiếng việt
简体中文
Español
Português
Log in
Sign Up
News
All
Editors' Picks
Forex
Commodities
Stocks
Indices
Cryptocurrencies
Technical Analysis
Economic Indicator
Other
Important Only
BRIEF-LB Pharmaceuticals Positive Topline Results From Phase 2 Trial Of Lb-102 In Schizophrenia
Jan 8 (Reuters) - Lb Pharmaceuticals: LB PHARMACEUTICALS: POSITIVE TOPLINE RESULTS FROM PHASE 2 TRIAL OF LB-102 IN SCHIZOPHRENIALB PHARMACEUTICALS: TRIAL MET PRIMARY ENDPOINT WITH STATISTICALLY SIGNIFICANT REDUCTION IN PANSS TOTAL SCORE AT ALL DOSE LEVELS VERSUS PLACEBOLB PHARMACEUTICALS: LB-102 WAS...
Reuters
7 hours ago
BRIEF-Jasper Therapeutics Reports Positive Data From Beacon Study Of Briquilimab In Chronic Spontaneous Urticaria
Jan 8 (Reuters) - Jasper Therapeutics Inc JSPR.O:JASPER THERAPEUTICS REPORTS POSITIVE DATA FROM BEACON STUDY OF BRIQUILIMAB IN CHRONIC SPONTANEOUS URTICARIAJASPER THERAPEUTICS INC - 66% MAINTAINED WELL CONTROLLED DISEASE AT 12 WEEKS IN 240MG COHORTJASPER THERAPEUTICS INC - DATA SUPPORTS COMMENCEMEN...
Reuters
7 hours ago
BRIEF-Quarterhill CFO Kyle Chriest To Leave Company
Jan 8 (Reuters) - Quarterhill Inc QTRH.TO:QUARTERHILL ANNOUNCES CFO DEPARTUREQUARTERHILL INC - CFO KYLE CHRIEST TO LEAVE COMPANYQUARTERHILL INC - MORGAN DEMKEY APPOINTED INTERIM CFO AT QUARTERHILLSource text: ID:nPnc8bV8VaFurther company coverage: QTRH.TO ((Reuters.Brief@thomsonreuters.com))
Reuters
7 hours ago
Morning News Call - U.S., January 8
(Morning News Call - U.S. edition will not be published on Thursday, January 9, as markets are closed in honor of former President Jimmy Carter)To access a PDF version of this newsletter, please click hereYou can read Morning News Call -- US via TOPNEWS U.S. Companies page.If you would like to recei...
Reuters
7 hours ago
BRIEF-Halozyme Reiterates 2024 Financial Guidance And Raises 2025 And Multi-Year Financial Guidance
Jan 8 (Reuters) - Halozyme Therapeutics Inc HALO.O:HALOZYME REITERATES 2024 FINANCIAL GUIDANCE AND RAISES 2025 AND MULTI-YEAR FINANCIAL GUIDANCEHALOZYME THERAPEUTICS INC: ANNOUNCES NEW $250 MILLION ACCELERATED SHARE REPURCHASEHALOZYME THERAPEUTICS: RAISES 2025 FINANCIAL GUIDANCE RANGES FOR TOTAL REV...
Reuters
7 hours ago
UPDATE 1-Meta to test showing eBay listings on Facebook Marketplace
Adds Meta's comment in paragraphs 3 and 5 STOCKHOLM, Jan 8 (Reuters) - Meta META.O said on Wednesday it would launch a test in Germany, France and the United States that will enable buyers to browse listings from eBay EBAY.O on Facebook Marketplace and then complete their transactions on eBay.The...
Reuters
7 hours ago
BRIEF-Canadian Solar's Unit E-Storage To Deliver 2 GWh Of Energy Storage Systems In UK For Copenhagen Infrastructure Partners
Jan 8 (Reuters) - Canadian Solar Inc CSIQ.O:CANADIAN SOLAR: CO'S UNIT E-STORAGE TO DELIVER 2 GWH OF ENERGY STORAGE SYSTEMS IN UK FOR COPENHAGEN INFRASTRUCTURE PARTNERSSource text: ID:nPn78wpYKaFurther company coverage: CSIQ.O ((Reuters.Brief@thomsonreuters.com))
Reuters
7 hours ago
BRIEF-I-Mab Announces Open Market Purchases Of Company American Depositary Shares By Board Member
Jan 8 (Reuters) - I-Mab IMAB.O:I-MAB ANNOUNCES OPEN MARKET PURCHASES OF COMPANY AMERICAN DEPOSITARY SHARES BY BOARD MEMBERI-MAB: CHAIRMAN WEI FU INFORMED CO OF HIS INTENT TO PURCHASE UP TO $2 MILLION OF CO'S ADSSSource text: ID:nPn7XmKzyaFurther company coverage: IMAB.O ((Reuters.Brief@thomsonreuter...
Reuters
7 hours ago
BRIEF-Boston Scientific Agrees To Acquire Bolt Medical
Jan 8 (Reuters) - Boston Scientific Corp BSX.N:BOSTON SCIENTIFIC ANNOUNCES AGREEMENT TO ACQUIRE BOLT MEDICAL, INC.BOSTON SCIENTIFIC CORP - DEAL VALUED AT $443 MILLION UPFRONT, UP TO $221 MILLION IN MILESTONESBOSTON SCIENTIFIC - ON 100% BASIS BEFORE CONSIDERATION OF CURRENT OWNERSHIP IN BOLT MEDICAL,...
Reuters
7 hours ago
BRIEF-Alesta Therapeutics Raises €65 Million Series A Financing To Advance Oral Small Molecules For Rare Diseases
Jan 8 (Reuters) - ALESTA THERAPEUTICS RAISES €65 MILLION SERIES A FINANCING TO ADVANCE ORAL SMALL MOLECULES FOR RARE DISEASESALESTA THERAPEUTICS: LEAD PROGRAM, ALE1, BEING DEVELOPED IN HYPOPHOSPHATASIA WITH PLANS TO ENTER CLINICAL DEVELOPMENT IN 2025Source text: ID:nPn81S4KPaFurther company coverage...
Reuters
7 hours ago
BRIEF-Avanti Helium Upsizes Private Placement Financing
Jan 8 (Reuters) - Avanti Helium Corp AVN.V:AVANTI HELIUM ANNOUNCES UPSIZE OF PRIVATE PLACEMENT FINANCINGAVANTI HELIUM CORP - OFFERING INCREASED TO 17,030,000 UNITS FOR $1.53 MILLIONSource text: ID:nCNW3jfL2aFurther company coverage: AVN.V ((Reuters.Brief@thomsonreuters.com))
Reuters
7 hours ago
BRIEF-Medipharm Labs and Brazil's Laboratório Teuto Enter Landmark Commercial Agreement
Jan 8 (Reuters) - Medipharm Labs Corp LABS.TO:MEDIPHARM LABS ENTERS LANDMARK COMMERCIAL AGREEMENT WITH LABORATÓRIO TEUTO IN BRAZILMEDIPHARM LABS CORP - INITIAL SHIPMENTS EXPECTED TO BEGIN NEW YEAR AFTER APPLICABLE IMPORT, EXPORT PERMITS FROM ANVISA AND HEALTH CANADA ARE RECEIVEDSource text: ID:nCNWD...
Reuters
7 hours ago
BRIEF-Moonlake Initiates Three New Clinical Trials And Expands Portfolio Of Indications For The Nanobody Sonelokimab
Jan 8 (Reuters) - MoonLake Immunotherapeutics MLTX.O:MOONLAKE INITIATES THREE NEW CLINICAL TRIALS AND FURTHER EXPANDS THE PORTFOLIO OF INDICATIONS FOR THE NANOBODY® SONELOKIMABMOONLAKE IMMUNOTHERAPEUTICS - PHASE 2 AND 3 DATA READ-OUTS EXPECTED IN 2025 AND 2026MOONLAKE IMMUNOTHERAPEUTICS - RUNNING SE...
Reuters
7 hours ago
AMD To Invest $20 Million In ABSCI
Jan 8 (Reuters) - Absci Corp ABSI.O:ABSCI AND AMD ANNOUNCE COLLABORATION AND STRATEGIC INVESTMENT TO ACCELERATE THE FUTURE OF AI DRUG DISCOVERYABSCI CORP - AMD TO INVEST $20 MILLION IN ABSCI
Reuters
7 hours ago
BRIEF-EVgo Receives First Drawdown From $1.25 Billion Loan Guarantee
Jan 8 (Reuters) - EVgo Inc EVGO.O:EVGO RECEIVES FIRST DRAWDOWN FROM $1.25 BILLION LOAN GUARANTEESource text: ID:nBw2WFpcZaFurther company coverage: EVGO.O ((Reuters.Brief@thomsonreuters.com))
Reuters
7 hours ago
BRIEF-Mirror Biologics and Merck KGaA Enter Clinical Trial Collaboration And Supply Agreement
Jan 8 (Reuters) - Merck KGaA MRCG.DE:MIRROR BIOLOGICS: ENTERED INTO A CLINICAL TRIAL COLLABORATION AND SUPPLY AGREEMENT WITH MERCK KGAASource text: ID:nGNX7VmpYqFurther company coverage: MRCG.DE ((Reuters.Brief@thomsonreuters.com))
Reuters
7 hours ago
United Natural Foods Announces Realignment Of Wholesale Business
Jan 8 (Reuters) - United Natural Foods Inc UNFI.N:UNITED NATURAL FOODS INC: RESTRUCTURES COMMERCIAL WHOLESALE ORGANIZATION INTO TWO PRODUCT-CENTERED DIVISIONSUNITED NATURAL FOODS ANNOUNCES REALIGNMENT OF WHOLESALE BUSINESSSource text: ID:nBwTN0TcaFurther company coverage: UNFI.N ((Reuters.Brief@thom...
Reuters
7 hours ago
Meta to test showing eBay listings on Facebook Marketplace
STOCKHOLM, Jan 8 (Reuters) - Meta META.O said on Wednesday it would launch a test in Germany, France and the United States that will enable buyers to browse listings from eBay EBAY.O on Facebook Marketplace and then complete their transactions on eBay.The European Commission had in November fined Me...
Reuters
7 hours ago
BRIEF-Solaris Resources Appoints Richard Hughes As CFO
Jan 8 (Reuters) - Solaris Resources Inc SLS.TO:SOLARIS RESOURCES INC: RICHARD HUGHES APPOINTED AS CFOSource text: ID:nGNX6t2xR3Further company coverage: SLS.TO ((Reuters.Brief@thomsonreuters.com))
Reuters
7 hours ago
Spain's Sanchez: richest man on planet attacks our institutions, fans hate
MADRID, Jan 8 (Reuters) - Spanish Prime Minister Pedro Sanchez on Wednesday attacked billionaire Elon Musk for his comments on politics without directly naming him. "The international ultra-right that we have been opposing in Spain for years, led in this case by the richest man on the planet, openl...
Reuters
7 hours ago
MEDIA-Livestream shopping app Whatnot raises $265 mln, pinning valuation at nearly $5 bln- TechCrunch
-- Source link: https://tinyurl.com/3kmkbtsm-- Note: Reuters has not verified this story and does not vouch for its accuracy ((Bengaluru newsroom, globalnewsmonitoring@thomsonreuters.com))
Reuters
7 hours ago
BRIEF-FDA Accepts Agios' Supplemental New Drug Application For Pyrukynd® (Mitapivat)
Jan 8 (Reuters) - Agios Pharmaceuticals Inc AGIO.O:FDA ACCEPTS AGIOS’ SUPPLEMENTAL NEW DRUG APPLICATION FOR PYRUKYND® (MITAPIVAT) IN ADULT PATIENTS WITH NON-TRANSFUSION-DEPENDENT AND TRANSFUSION-DEPENDENT ALPHA- OR BETA-THALASSEMIAAGIOS PHARMACEUTICALS INC - PDUFA GOAL DATE FOR PYRUKYND SNDA IS SEPT...
Reuters
7 hours ago
RPT-BREAKINGVIEWS-CATL’s $5 bln listing future-proofs enviable lead
The author is a Reuters Breakingviews columnist. The opinions expressed are her own. Refiles to remove hyperlinks in third paragraph.By Katrina Hamlin HONG KONG, Jan 8 (Reuters Breakingviews) - The world's largest battery maker is determined to shore up its dominance. A planned Hong Kong listing ...
Reuters
7 hours ago
EU climate plans at risk from public funding gap, ECB paper shows
FRANKFURT, Jan 8 (Reuters) - The European Union risks falling significantly short later this decade of the public funds it needs to achieve its climate goals, a study published by the European Central Bank showed on Wednesday.The EU aims to be climate-neutral by 2050 but this will involve huge inves...
Reuters
7 hours ago
FACTBOX-Data center companies investing in Brazil
SAO PAULO, Jan 8 (Reuters) - Brazil is rapidly emerging as a key hub for data centers, with billions of dollars in investments expected in the coming years. The surge is largely attributed to the exponential rise of artificial intelligence and growth constraints in larger markets in the U.S. and Eur...
Reuters
7 hours ago
View More
next page